A woman in her mid-50s with breast carcinoma was presented. She was six weeks post-op from a FIG. 8. A six-week postoperative large, complex seroma located at the lumpectomy site. This seroma was too large for the MammoSite Radiation Therapy System catheter. Multicatheter brachytherapy was performed instead.
Sonography of the breast is a rapidly expanding specialty area. It is routinely used in conjunction with mammography. The role of sonography in breast examinations primarily consists of a targeted study focusing on a specific abnormality seen on a mammogram. Sonography is also used to evaluate palpable breast masses, dense breast tissue, and breast implants. Sonographic guidance is often used in interventional procedures such as core needle biopsies, fine needle aspirations, needle wire localizations, and handheld mammotomes. Recently, the role of sonography in breast care has expanded. Breast brachytherapy (internal radiation therapy) is a type of radiotherapy that can be used in breast conservation therapy (BCT). This article is limited to the role of sonography in BCT breast brachytherapy. The surgical technique, radiation dosimetry, computed tomography, and mammographic roles are not discussed in detail.
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The American Cancer Society (ACS) recommends that all women age 20 and older perform monthly breast self-examinations (BSE). In addition, women age 40 and older should have a clinical breast examination (CBE) done by a doctor or trained nurse every year. Women between the ages of 20 and 39 should have a CBE every 3 years. All women age 40 and older should have annual mammograms. 1 Mammography and breast sonography are routinely performed on patients whose BSE or CBE have shown a change. If a questionable mammographic or sonographic abnormality is reported, an interventional procedure such as a biopsy can be performed (Fig. 1A, 1B) . A biopsy can be performed in several different ways, depending on the visibility and location of the area in question. If a positive diagnosis of breast cancer is confirmed, a lumpectomy (surgical removal of the tumor and its margins, including some lymph nodes) is performed. The tumor is staged to determine the patient's next step in treatment.
Breast conservation therapy is a treatment available for early-stage breast cancer patients. The method of breast conservation therapy (BCT) began as a combination of a surgical lumpectomy followed by five to seven weeks of external beam radiation therapy to the whole breast and chemotherapy, if required. Because of the amount of time the external radiation therapy treatment required, several patients encountered conflicts with their work and/or family schedules. The distance from the treatment centers was another big challenge for many patients. These challenges prompted many of the patients to choose mastectomy (total breast removal) rather than BCT.
The advent of interstitial breast brachytherapy used in BCT has reduced the radiation therapy treatment time from five to seven weeks to just one week. The treatments are done two times a day and require approximately 15 to 20 minutes per treatment. Because the devices are located inside the breast, the tissue margins that are at the highest risk for tumor recurrence receive a therapeutic dose of radiation while the surrounding healthy tissue exposure is minimal. 2 The criteria for candidates of BCT brachytherapy are the following:
• The patient must be 45 years of age or older. • The tumor size should be less than 3 cm with negative surgical margins (by National Surgical Adjuvant Breast and Bowel Project standards). The lymph nodes should be negative (N0). If one to three nodes are positive (N1), clinical judgment should be used.
• There should be no metastatic disease (M0).
The patient's tumor type and medical history must also be considered. 3 Multicatheter interstitial breast brachytherapy was introduced approximately ten years ago as the first internal radiation therapy procedure to be used in BCT. The procedure involves placing several tiny flexible catheters (resembling spaghetti) through the breast at the lumpectomy site ( Fig. 2) . These catheters can be placed into the breast under sonographic or stereotactic guidance. Patients with large, pendulous breasts generally have the catheters inserted using stereotactic guidance and a special template. Patients with smaller breasts generally have the catheters inserted under sonographic guidance.
Prior to multicatheter placement, the postsurgical lumpectomy site must first be evaluated by sonography to locate a postsurgical fluid collection called a seroma (Fig. 3 ). The seroma must be partially aspirated under sonographic guidance prior to the stereotactic catheter insertion. Approximately 85% to 90% of the seroma should be aspirated, and a small amount of x-ray contrast and air should be injected into the cavity.
This enables visualization of the seroma cavity by the stereotactic equipment.
When the catheters are inserted under sonographic guidance, the seroma should be partially aspirated if it is very large. After aspirating, the seroma borders should be outlined on the skin surface for proper placement of the catheters. The catheters should be placed into the margins of the lumpectomy cavity. After the catheters are in place, a computed tomography (CT) examination is performed to determine the exact location of each catheter.
A radiation physicist determines a dosimetry dose, and a radiation oncology team connects the ends of the catheters to a high-dose rate (HDR) afterloader. The afterloader delivers the radiation treatment to the margins of the lumpectomy site through the catheters that are inside the breast. 4 Another method of breast brachytherapy, the MammoSite Radiation Therapy System (RTS), was approved by the US Food and Drug Administration (FDA) in May 2002 ( Fig. 4) . It also provides a way to deliver internal radiation therapy to the surgical margins of the lumpectomy site and involves inserting a single catheter with a small balloon at one end into the seroma cavity. The catheter has two lumens, one for inflating the balloon and the other for inserting the radiation source ( Fig. 5 ). It can be inserted at the time of the surgical lumpectomy or up to ten weeks postoperatively. If insertion is performed during the surgical lumpectomy, the surgeon will make a spherical cavity. The MammoSite catheter is inserted through a trocar path into the lumpectomy cavity. The balloon is then inflated with a mixture of x-ray contrast and saline. This enables visualization of the balloon with CT and mammography. Sonography is used in surgery to evaluate the balloon after the incision is closed to check shape, size, location, and competency of the balloon and to obtain a skin-to-balloon edge measurement (Fig. 6 ).
The MammoSite insertion can also be done up to ten weeks postoperatively. Additional criteria must be considered prior to a postsurgical MammoSite catheter insertion. The lumpectomy site should be evaluated by sonography to locate a seroma. The seroma size should be measured in three dimensions, and a volume should be calculated using the following ellipsoid volume formula: volume cc = (length diam/2) × (width diam/2) × (height diam/2) × 4/3π). The volume of the seroma should be between 15 and 40 cc. The maximum diameter should be below 7 cm, and the minimum should be above 1.5 cm. A skin-to-seroma edge distance should also be measured ( Fig. 7 ). This distance should be no less than 5 mm in thickness to reduce possible skin damage from the radiation source. If any of these criteria are not adequate, the multicatheter brachytherapy technique should be used instead.
If the criteria are adequate, the seroma must first be located by sonography. After the seroma is identified, the sonographer marks a spot along the patient's lumpectomy scar above the seroma for the surgeon to reopen. The surgeon makes a small incision into the scar, and the catheter is inserted through the incision. The catheter balloon is then inflated with a mixture of x-ray contrast and saline. The balloon is evaluated with sonography during the inflation to evaluate the size, shape, location, and competency of the balloon and to obtain a skin- to-balloon edge measurement. The radiation source is later inserted into the catheter in the middle of the balloon. The radiation treatment is delivered internally to the margins of the lumpectomy site. 5 Both procedures can be used as a primary source of radiotherapy or in conjunction with the external beam radiation therapy. The patient is not radioactive between treatments because the source is removed from the catheters. The patient may experience minor discomfort during the procedure. The catheters are removed after all the treatments are complete. The patient is placed on close clinical follow-up care.
Case Report 1
A woman in her mid-80s with breast carcinoma was presented. She was four weeks post-op from a surgical lumpectomy in another facility. Her lumpectomy margins and her lymph nodes were negative. She was referred to our facility for a possible MammoSite RTS placement. The patient's lumpectomy site was examined with a GE Logiq 400 Pro Series sonography unit with an LA39 linear 11-MHz transducer to determine if a seroma was present. A large, complex seroma was located and measured in three dimensions. The size of the seroma was approximately 7.5 × 5.5 × 8.7 cm with a volume of approximately 188 cc. The seroma was determined to be too large for the MammoSite insertion (Fig. 8) , and the patient was scheduled for multicatheter interstitial breast brachytherapy one week later. The patient's breast size was large enough to enable the catheter placement to be done under stereotactic guidance using a special template.
The patient was prescribed some mild oral antianxiety medication and a topical skin anesthetic. She was instructed to take her prescribed medication on the day of the procedure. She was also told to apply the topical skin anesthetic to her breast one hour before arriving.
The patient was rescanned with sonography when she returned. The seroma size remained the same.
The seroma was aspirated under sonographic guidance prior to the catheter placement. The patient was positioned supine, with her ipsilateral arm raised above her head and resting on the pillow.
The entry site for the aspiration was marked on the patient's skin with a nontoxic ink skin marker. The patient's skin was prepped and draped with sterile towels. A sterile transducer sheath was placed on the sonographic transducer. Sterile transmission gel was also used. A local anesthetic was injected into the entry site. Using sonographic guidance in a longitudinal scan plane, an 18-gauge 1 1 2 -inch needle was inserted into the seroma. Approximately 85% of the seroma was aspirated. A small amount of x-ray contrast and air was injected into the cavity. The patient was covered and taken to the stereotactic room.
The brachytherapy catheters were placed into the margins of the seroma using stereotactic guidance and a special template. The cavity was easily visualized on mammography due to the contrast media and air that was injected into it. A total of 36 catheters were placed into the patient's breast. The patient had a CT scan to evaluate the catheters, and a radiation physicist determined a dosimetry dose. The patient began radiotherapy treatments two days later. This combination of modalities using sonography, mammography, and computed tomography enabled the procedure to be done with ease, accuracy, and efficiency. surgical lumpectomy in another facility. Her surgical margins were negative, and she had one positive sentinel node. She was referred to our facility for a possible MammoSite placement. The patient's lumpectomy site was examined with a GE Logiq 400 Pro Series sonography system with an LA39 linear 11-MHz transducer to locate a seroma. A small .9 × .35 × 1.82 cm seroma was identified. This had a volume of less than 1 cc (Fig. 9) . The cavity was determined to be too small for the MammoSite placement. The patient was scheduled for multicatheter brachytherapy two weeks later. The patient's breast size was small enough to en-able the catheters to be placed under sonographic guidance.
The patient followed the same preprocedural prep as in case report 1. The patient was positioned supine, with her ipsilateral arm raised above her head and resting on a pillow. The patient was examined with an ATL/Phillips HDI 5000 sonography unit with a linear 50-mm L12-5 transducer. The seroma borders were located with sonography and precisely outlined on the patient's skin using a nontoxic ink skin marker. A second outline, approximately 2 cm from the first, was made around the first outline ( Figs. 10-11) . The en- try and exit points were determined (in this case, the needles were to be placed from inferior to superior). Two rows of "dots" were made superior and inferior to the seroma outlines. Each dot was placed 1.5 cm apart in a straight line. The two rows of dots staggered the other; they did not line up directly behind the other. The innermost row of dots provided a guide for the shallow catheter placement, and the outermost row provided a guide for the deeper catheter placement. Each superior dot corresponded to an inferior dot. Basically, the needles would "connect the dots" (Fig. 12) . After the points of entry and exit were marked, the patient was prepped and draped with sterile towels. The pa-tient's view of the procedure was also obscured with a large sterile drape suspended on IV poles and placed below her chin. The sonographic transducer was covered with a sterile sheath, and sterile transmission gel was used.
Each dot was injected with local anesthesia (Fig.  13) . Because a copious amount of local anesthetic was used, it was diluted in a bag of saline to prevent toxicity. The deep and shallow dots were anesthetized from entry to exit under constant sonographic guidance in a longitudinal scan plane using a 22gauge 3 1 2 -inch spinal needle (Fig. 14) . Once the breast was anesthetized, each catheter needle was inserted under constant sonographic guidance in a longitudinal scan plane inferiorly from the entry dot through the breast to the corresponding superior exit dot. The deeper row of needles was inserted first. The deep row was placed along the chest wall below the seroma at the retromammary space (space between the posterior breast tissue and pectoralis muscle) (Fig. 15 ).
The shallow row was inserted after all the deep needles were in place. A distance was measured from the skin surface to the anterior wall of the seroma. The shallow catheter placement depth was determined by dividing this distance in half. (In this case, the skin-to-anterior seroma edge distance was 10 mm. The shallow catheter depth was calculated to be 5 mm.) A measurement caliper was placed on the imaging screen from the skin surface to a perpendicular point 5 mm below the skin surface. This caliper provided a "target" for the physi- cian to "aim" at while inserting the shallow needles ( Fig. 16) . A total of 14 needles were placed through the breast at the margins of the seroma (Fig. 17) . After all the needles were in place, they were imaged by sonography in the transverse scan plane. This allowed visualization of both rows of needles. Each needle showed up on the image as an echogenic dot (Fig. 18) . A distance between the anterior and posterior needles was calculated for each set. This distance between the deep and shallow rows should be less than 16 mm apart. In this case, one distance measured approximately 19 mm. An additional needle was inserted between the shallow and deep needle at this point. After all the needles were in position, the catheters were inserted through the needles (Fig. 19) . The needles were re-moved, leaving the catheters in place. Small "button-like" caps were placed on the ends of the catheters.
The patient was evaluated with CT, and a dosimetry dose was determined. She began radiotherapy treatments two days later. The patient complained of mild pain two times and was given two doses of oral pain medication.
Case Report 3
A woman in her early 70s with breast carcinoma confirmed by a previous stereotactic biopsy was presented. It was predetermined that the patient was a candidate for a surgical lumpectomy followed by a MammoSite RTS catheter placement. A needle wire localization was performed with digital mammography. The patient was sent to the nuclear medicine lab and then to the surgical suite. The surgeon performed two sentinel node excisions and a lumpectomy. The pathologist confirmed the nodes to be negative for micro-metastases and individual tumor cells during the surgery. The pathologist also confirmed the lumpectomy margins to be negative during the surgery.
A trocar was inserted into the lateral side of the patient's breast while the lumpectomy incision remained open. The trocar was removed, and a MammoSite catheter was inserted through the trocar path. The balloon was inflated with a mixture of x-ray contrast and saline. The lumpectomy cavity was "fitted" to the balloon.
The balloon was deflated and pulled back into the trocar path. The incision was closed, and the catheter was readvanced back into the cavity. The balloon was reinflated after the incision was closed. Sonographic imaging of the balloon was performed in surgery using a GE Logiq 400 Pro Series system with an LA39 linear 11-MHz transducer. The transducer was covered with a sterile probe sheath, and sterile transmission gel was used. The sonographer also scrubbed in for the procedure and put on a sterile surgical gown and gloves. The balloon was evaluated with sonography in the surgical room to determine the shape, conformity to the cavity, and proper inflation of the balloon and to measure a skin-to-balloon edge thickness (Fig. 20) .
After a two-day recovery, the patient was scheduled for a CT examination of the MammoSite and radiation therapy to begin her radiotherapy treatment.
Case Report 4
A woman in her late 60s was referred to our facility for a work-up on an abnormality seen on a mammogram from another facility. She was evaluated with a GE Logiq 400 Pro Series sonography system and an 11-MHz linear LA39 transducer. A solid, noncompressible mass with poor margins and posterior shadowing was imaged. A sonographicguided core needle biopsy was performed on the patient the same day.
The patient's biopsy results confirmed a poorly differentiated invasive ductal carcinoma. The patient was offered a lumpectomy with MammoSite placement. She chose to have the lumpectomy but wanted to research the MammoSite procedure before insertion. Her lumpectomy margins and nodes were negative.
The patient returned to our facility four weeks later for a sonographic evaluation of her seroma and a possible MammoSite placement. Her seroma measured 5.44 × 2.30 × 4.58 cm with a volume of 30 cc. Her skin-to-anterior seroma border distance was 15 mm. The criteria for the MammoSite insertion indicated that she was an optimal candidate for the procedure. The patient was scheduled for a MammoSite placement the following week.
The patient was taken to the surgical suite. She was sedated with conscious sedation and monitored by an anesthesiologist. She was placed supine with her ipsilateral arm extended out to her side. She was prepped and draped with sterile drapes. The sonographer scrubbed and put on a sterile gown and gloves. The transducer was covered with a sterile sheath, and sterile transmission gel was used.
The seroma was evaluated and remeasured for size and location. Using a sterile surgeon's marking pen, the sonographer made a mark along the patient's lumpectomy scar at the site of the seroma. The surgeon made a small incision at the mark along the lumpectomy scar. He drained the contents of the seroma into a sterile basin and sent it for lab analysis. The MammoSite catheter was inserted into the incision and advanced into the seroma cavity. Under constant sonographic guidance, the balloon was slowly inflated with a mixture of x-ray contrast and saline (rapid inflation caused patient discomfort). The balloon was evaluated for size, contour, location, and shape. A skin-to-balloon edge distance was also measured.
The patient was scheduled for a CT examination, and a radiation physicist determined a dosimetry dose. She began radiotherapy treatments two days later.
Discussion
This article presents four basic techniques of inserting interstitial breast brachytherapy devices and the role sonography plays in each technique. Each patient received radiation therapy to the surgical margins of her lumpectomy site, although the approach to insert the devices and the devices themselves varied.
The patient's pain level in all cases was reported to be low to none, depending on each individual's pain tolerance. Short-term follow-up revealed no complications. Long-term follow-up is being conducted to ensure the effectiveness of the treatments.
Conclusion
Interstitial breast brachytherapy used in BCT has provided more options in the treatment process. The ease and accuracy of the placement of the devices have made breast brachytherapy more appealing. There is minimal discomfort during the radiotherapy treatments, and the treatments are less time-consuming, requiring one week instead of five to seven weeks to complete.
Long-term clinical studies have shown the survival results in BCT to be as effective as in mastectomy. 2 The number of facilities offering interstitial breast brachytherapy is growing rapidly. Multicatheter breast brachytherapy implantation can be performed accurately and efficiently using sonographic or mammographic guidance. The MammoSite RTS device has simplified the implantation process even more.
The combined imaging technology of sonography, computed tomography, and mammography has enabled the devices to be inserted and monitored with ease, reproducibility, and accuracy.
